November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
April 24, 2026 - 04:02
Next Technology Drive Construction to Cause Weekend Traffic Disruptions in MadisonMADISON, AL – Motorists in Madison should prepare for significant traffic disruptions along Next Technology Drive this weekend as construction crews begin a new phase of roadway improvements. The...
April 23, 2026 - 00:48
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICERAmgen has announced the retirement of Dr. David M. Reese, the company`s Executive Vice President and Chief Technology Officer. The decision is effective as of the end of this year, concluding a...
April 22, 2026 - 12:12
Japan lowers restrictions on weapon and technology exportsIn a historic policy shift, the Japanese government has approved a sweeping revision to its strict defense export controls, effectively lifting a decades-long ban on selling lethal weapons abroad....
April 21, 2026 - 17:12
Technology Guide: Modern cellular analysis in early drug discoveryThe initial stages of drug discovery are being transformed by a new generation of cellular analysis technologies. By moving beyond traditional, one-dimensional assays, scientists are now able to...